NovantaNOVT
About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Employees: 3,000
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
67% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 36
10% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 106
6% more funds holding
Funds holding: 301 [Q4 2024] → 320 (+19) [Q1 2025]
0% more call options, than puts
Call options by funds: $524K | Put options by funds: $524K
0.85% less ownership
Funds ownership: 99.06% [Q4 2024] → 98.21% (-0.85%) [Q1 2025]
17% less capital invested
Capital invested by funds: $5.43B [Q4 2024] → $4.52B (-$919M) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for NOVT.
Financial journalist opinion









